Cancer statistics, 2016

Siegel, Rebecca L.; Miller, Kimberly D.; Jemal, Ahmedin

doi:10.3322/caac.21332

Cited by 16,003Global Cancer Incidence and ScreeningColorectal Cancer Screening and DetectionScience, Research, and Medicine

Cancer statistics, 2016

Open access

Siegel, Rebecca L., Miller, Kimberly D., Jemal, Ahmedin·2016·CA: A Cancer Journal for Clinicians

DOI 10.3322/caac.21332

Open this paper in CoChat — free account

Abstract

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States. Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009‐2012), much of which is because of recent rapid declines in prostate cancer diagnoses. The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012. Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease. Among children and adolescents (aged birth‐19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia. Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population. CA Cancer J Clin 2016;7–30. © 2015 American Cancer Society.

Integrity signals

Registry

Crossref · 10.3322/caac.21332

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Thyroid carcinomas are more prevalent among women.
“Thyroid carcinomas are more prevalent among women.”
From Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells (2017) · cites this paper as [5]

SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404 · see citing works
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064 · see citing works
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990 · see citing works
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,814 · see citing works
Breast cancer statistics, 2019
Desantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Sauer, A. G., Jemal, A., & Siegel, R. L. (2019) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,126 · see citing works
Self-citation
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932 · see citing works
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L. D., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,456 · see citing works
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
Edwards, B. K., Ward, E., Kohler, B. A., Eheman, C., Zauber, A. G., Anderson, R. N., Jemal, A., Schymura, M. J., Lansdorp‐Vogelaar, I., Seeff, L. C., et al. (2010) · Cancer · doi:10.1002/cncr.24760 · Cited by 2,002 · see citing works
Self-citation
Breast Cancer Statistics
Ma, J., & Jemal, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,918 · see citing works
Self-citation
Cancer Disparities by Race/Ethnicity and Socioeconomic Status
Ward, E., Jemal, A., Cokkinides, V. E., Singh, G. K., Cardinez, C. J., Ghafoor, A., & Thun, M. J. (2004) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.2.78 · Cited by 1,796 · cited 1× · see citing works
“prevention and early detection, timely diagnosis, and optimal treatment.(60,61) Even among Medicare-insured patients,”
BackgroundSelf-citation
International Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,688 · cited 1× · see citing works
“the International Classification of Childhood Cancer (ICCC).(13) Causes of death were classified according to the International Classification of Diseases.”
Method
The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General, 2014Us Department of Health and Human Services Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for: Critique
Courtney, R. J. (2015) · Drug and Alcohol Review · doi:10.1111/dar.12309 · Cited by 1,438 · see citing works
Breast cancer statistics, 2011
Desantis, C. E., Siegel, R. L., Bandi, P., & Jemal, A. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20134 · Cited by 1,338 · see citing works
Self-citation
Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005
Chen, A. Y., Jemal, A., & Ward, E. (2009) · Cancer · doi:10.1002/cncr.24416 · Cited by 998 · see citing works
Self-citation
Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control
Jemal, A., Thun, M. J., Ries, L. A. G., Howe, H. L., Weir, H. K., Ward, E., Wu, X., Eheman, C. R., Anderson, R. N., Ajani, U. A., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn389 · Cited by 946 · cited 2× · see citing works
“The largest geographic variation in cancer occurrence by far is for lung cancer, reflecting the large historical and continuing differences in smoking prevalence among states.(54) For example, lung cancer incidence rates in Kentucky, which has historically had the highest smoking prevalence, are 3.”
Self-citation
Kim H‐J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351
Kim, H. (2001) · Statistics in Medicine · doi:10.1002/sim.811 · Cited by 885 · see citing works
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
Draisma, G., Etzioni, R., Tsodikov, A., Mariotto, A. B., Wever, E., Gulati, R., Feuer, E. J., & de Koning, H. J. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 795 · cited 1× · see citing works
“Routine screening with the PSA test is no longer recommended because of growing concerns about high rates of overdiagnosis, estimated at 23% to 42% for screen-detected cancers.(27,28) Despite declines in the prevalence of PSA screening from 2010 to 2013, one-third of men aged 65 years and older with limited life expec…”
Background
The Role of Increasing Detection in the Rising Incidence of Prostate Cancer
Potosky, A. L. (1995) · JAMA · doi:10.1001/jama.1995.03520310046028 · Cited by 674 · cited 2× · see citing works
“1 in the District of Columbia, likely reflecting both state differences in PSA testing prevalence and population demographics.(24) In contrast, state variations for other cancer types are smaller in both absolute and relative terms.”
Background
Recent patterns in gastric cancer: A global overview
Bertuccio, P., Chatenoud, L., Levi, F., Praud, D., Ferlay, J., Negri, E., Malvezzi, M., & Vecchia, C. L. (2009) · International Journal of Cancer · doi:10.1002/ijc.24290 · Cited by 620 · cited 1× · see citing works
“sumption of fresh fruits and vegetables because of advances in food preservation techniques (eg, refrigeration).(49)”
Background
Survival of Blacks and Whites After a Cancer Diagnosis
Bach, P. B. (2002) · JAMA · doi:10.1001/jama.287.16.2106 · Cited by 514 · cited 1× · see citing works
“prevention and early detection, timely diagnosis, and optimal treatment.(60,61) Even among Medicare-insured patients,”
Background
Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults
Anderson, W. F. (2010) · JAMA · doi:10.1001/jama.2010.496 · Cited by 460 · cited 1× · see citing works
“subtypes of stomach cancer are increasing for some subsets of the US population for reasons that remain unknown.(50,51) The decline in cancer death rates over the past 2 decades”
Background
Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group
Albain, K. S., Unger, J. M., Crowley, J. J., Coltman, C. A., & Hershman, D. L. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp175 · Cited by 458 · cited 1× · see citing works
“However, an analysis of clinical trial data showed that black women were less likely than white women to survive their breast cancer despite uniform treatment, even after controlling for stage of disease, tumor characteristics, follow-up, and socioeconomic status.(69) Cancer incidence and death rates are lower among A…”
Method
Trends in Breast Cancer by Race and Ethnicity
Ghafoor, A., Jemal, A., Ward, E., Cokkinides, V. E., Smith, R. A., & Thun, M. J. (2003) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.6.342 · Cited by 450 · cited 1× · see citing works
“The historically higher incidence rate among white women is thought to reflect a combination of factors that affect both diagnosis (more prevalent mammography) and underlying disease occurrence (such as later age at first birth and greater use of menopausal hormone therapy).(63) However, a recent study reported that b…”
BackgroundSelf-citation
Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer?
Welch, H. G. (2000) · JAMA · doi:10.1001/jama.283.22.2975 · Cited by 449 · cited 1× · see citing works
“However, it is important to realize that screening, as well as other changes in detection practices, introduces lead time bias in survival rates, thereby reducing their usefulness in measuring progress against cancer.(47) For example, the jump in 5-year relative survival rates for prostate cancer from 83% in the late…”
Background
Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer
Tammemägi, M. C. (2005) · JAMA · doi:10.1001/jama.294.14.1765 · Cited by 428 · see citing works
Quantifying the role of PSA screening in the US prostate cancer mortality decline
Etzioni, R., Tsodikov, A., Mariotto, A. B., Szabó, A., Falcon, S., Wegelin, J., diTommaso, D., Karnofski, K., Gulati, R., Penson, D. F., et al. (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9083-8 · Cited by 417 · cited 1× · see citing works
“each down about 50% as a result of improvements in early detection and treatment.(8,33,52,53) Lung cancer death rates”
Background
Long-term trends in cancer mortality in the United States, 1930-1998
Wingo, P. A., Cardinez, C. J., Landis, S., Greenlee, R. T., Ries, L. A. G., Anderson, R. N., & Thun, M. J. (2003) · Cancer · doi:10.1002/cncr.11380 · Cited by 385 · see citing works
Screening for Prostate Cancer With the Prostate-Specific Antigen Test
Hayes, J. H., & Barry, M. J. (2014) · JAMA · doi:10.1001/jama.2014.2085 · Cited by 360 · cited 1× · see citing works
“Routine screening with the PSA test is no longer recommended because of growing concerns about high rates of overdiagnosis, estimated at 23% to 42% for screen-detected cancers.(27,28) Despite declines in the prevalence of PSA screening from 2010 to 2013, one-third of men aged 65 years and older with limited life expec…”
Background
The reversal of fortunes: trends in county mortality and cross-county mortality disparities in the United States
Ezzati, M., Friedman, A. B., Kulkarni, S. C., & Murray, C. J. L. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050066 · Cited by 346 · cited 1× · see citing works
“Geographic patterns in cancer occurrence reflect differences in risk factors, such as smoking and obesity, as well as disparities in the national distribution of poverty and access to health care, which have increased over time.(72,73) The largest geographic variation in cancer occurrence by far is for lung cancer, re…”
Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers
Zeng, C., Wen, W., Morgans, A. K., Pao, W. J., Shu, X., & Zheng, W. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2014.161 · Cited by 321 · see citing works
Epidemiology of tobacco use in the United States
Giovino, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205808 · Cited by 320 · see citing works
Tobacco Control and the Reduction in Smoking-Related Premature Deaths in the United States, 1964-2012
Holford, T. R., Meza, R., Warner, K. E., Meernik, C., Jeon, J., Moolgavkar, S. H., & Levy, D. T. (2014) · JAMA · doi:10.1001/jama.2013.285112 · Cited by 317 · cited 1× · see citing works
“1964 have resulted in 8 million fewer premature smokingrelated deaths, one-third of which are due to cancer.(55,56)”
Background
Anthropometric factors and endometrial cancer risk: A systematic review and dose-response meta-analysis of prospective studies
Aune, D., Navarro Rosenblatt, D. A., Chan, D. S. M., Vingeliene, S., Abar, L., Vieira, A. R., Greenwood, D. C., Bandera, E. V., & Norat, T. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv142 · Cited by 288 · cited 1× · see citing works
“most obese women, some elevation in risk is apparent even within the normal BMI range.(38) It is important to note”
Background
Impact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
Clegg, L. X. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.20.1537 · Cited by 282 · cited 1× · see citing works
“cancer) and provides a more accurate portrayal of the cancer burden in the most recent time period.(17) For example,”
Background
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors
Warner, E. T., Tamimi, R. M., Hughes, M. E., Ottesen, R. A., Wong, Y., Edge, S. B., Theriault, R. L., Blayney, D. W., Niland, J. C., Winer, E. P., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.1349 · Cited by 279 · see citing works
Racial disparities in cancer therapy
Gross, C. P., Smith, B. D., Wolf, E. R., & Andersen, M. S. (2008) · Cancer · doi:10.1002/cncr.23228 · Cited by 246 · see citing works
Adiposity and risk of thyroid cancer: A systematic review and meta-analysis
Schmid, D., Ricci, C., Behrens, G., & Leitzmann, M. F. (2015) · Obesity Reviews · doi:10.1111/obr.12321 · Cited by 244 · see citing works
Disparities in Cancer Mortality and Incidence Among American Indians and Alaska Natives in the United States
White, M. C., Espey, D. K., Swan, J., Wiggins, C. L., Eheman, C. R., & Kaur, J. S. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301673 · Cited by 224 · cited 2× · see citing works
“Regional variation in the prevalence of these risk factors likely contributes to the striking geographic differences in kidney cancer death rates among AI/AN men, which are highest in the Southern and Northern Plains and lowest in the East and Pacific Coast.71 Regional Variations in Cancer Rates Tables 10 and 11 depic…”
Background
Trends in Colorectal Cancer Incidence Rates in the United States by Tumor Location and Stage, 1992–2008
Siegel, R. L., Ward, E., & Jemal, A. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1020 · Cited by 217 · cited 1× · see citing works
“However, the recent rapid declines are likely driven by the increased uptake of screening with colonoscopy, which can prevent cancer by allowing for the removal of precancerous lesions.(34,35) Among adults aged 50 to 75 years, colonoscopy use increased from 19% in 2000 to 55% in 2013.”
BackgroundSelf-citation
Cigarette smoking among successive birth cohorts of men and women in the United States during 1900-80.
Harris, J. E. (1983) · PubMed · Cited by 209 · see citing works
National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen–Based Screening
Drazer, M. W., Huo, D., & Eggener, S. E. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.6532 · Cited by 194 · see citing works
Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992–2001
Cress, R. D., Morris, C. R., Ellison, G. L., & Goodman, M. T. (2006) · Cancer · doi:10.1002/cncr.22011 · Cited by 172 · see citing works
Underlying Causes of the Black-White Racial Disparity in Breast Cancer Mortality: A Population-Based Analysis
Menashe, I., Anderson, W. F., Jatoi, I., & Rosenberg, P. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp176 · Cited by 170 · see citing works
Divergent trends for gastric cancer incidence by anatomical subsite in US adults
Camargo, M. C., Anderson, W. F., King, J. B., Correa, P., Thomas, C. C., Rosenberg, P. S., Eheman, C. R., & Rabkin, C. S. (2011) · Gut · doi:10.1136/gut.2010.236737 · Cited by 164 · cited 1× · see citing works
“subtypes of stomach cancer are increasing for some subsets of the US population for reasons that remain unknown.(50,51) The decline in cancer death rates over the past 2 decades”
Background
Racial/Ethnic Disparities in Time to Follow-Up after an Abnormal Mammogram
Press, R., Carrasquillo, O., Sciacca, R. R., & Giardina, E. V. (2008) · Journal of Women s Health · doi:10.1089/jwh.2007.0402 · Cited by 164 · see citing works
Follicular Thyroid Cancer Incidence Patterns in the United States, 1980–2009
Aschebrook‐Kilfoy, B., Grogan, R. H., Ward, M. H., Kaplan, E. L., & Devesa, S. S. (2013) · Thyroid · doi:10.1089/thy.2012.0356 · Cited by 137 · see citing works
Deaths Due to Cigarette Smoking for 12 Smoking-Related Cancers in the United States
Siegel, R. L., Jacobs, E. J., Newton, C. C., Feskanich, D., Freedman, N. D., Prentice, R. L., & Jemal, A. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.2398 · Cited by 125 · cited 1× · see citing works
“one-half of all deaths from cancers of the oral cavity, esophagus, and urinary bladder are caused by smoking.(57) TABLE 8.”
BackgroundSelf-citation
A New Method of Estimating United States and State-level Cancer Incidence Counts for the Current Calendar Year
Pickle, L. W., Hao, Y., Jemal, A., Zou, Z., Tiwari, R. C., Ward, E., Hachey, M., Howe, H. L., & Feuer, E. J. (2007) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.30 · Cited by 114 · cited 1× · see citing works
“lifestyle factors, medical settings, and cancer screening behaviors as predictors of incidence.(19) Then these counts”
BackgroundSelf-citation
Chapter 4: Changing Patterns in Breast Cancer Incidence Trends
Holford, T. R., Cronin, K. A., Mariotto, A. B., & Feuer, E. J. (2006) · JNCI Monographs · doi:10.1093/jncimonographs/lgj016 · Cited by 111 · cited 1× · see citing works
“1980s reflects increases in both lung cancer, as a result of the tobacco epidemic, and breast cancer, because of changes in female reproductive patterns and the increased detection of asymptomatic disease during the rapid uptake of mammography screening.(25) Table 5 presents the annual percent change in delayadjusted…”
Background
Deaths: Final Data for 2012.
Murphy, S. L., Kochanek, K. D., Xu, J., & Heron, M. P. (2015) · PubMed · Cited by 104 · see citing works
Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008.
Jamison, P. M., Noone, A.-M., Ries, L. A. G., Lee, N. C., & Edwards, B. K. (2013) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0996 · Cited by 101 · see citing works
Bigger bodies: Long-term trends and disparities in obesity and body-mass index among U.S. adults, 1960–2008
Ljungvall, Å., & Zimmerman, F. J. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2012.03.003 · Cited by 100 · cited 1× · see citing works
“white women, perhaps due to steeper temporal increases in obesity among black women.(37) Excess weight increases”
Background
Increasing Lung Cancer Death Rates Among Young Women in Southern and Midwestern States
Jemal, A., Ma, J., Rosenberg, P. S., Siegel, R. L., & Anderson, W. F. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.6098 · Cited by 97 · cited 1× · see citing works
“Women took up smoking in large numbers later than men, first initiated smoking at older ages, and were slower to quit, including recent upturns in smoking prevalence in some birth cohorts.(31,32) Declines in lung cancer incidence and death rates continue to be larger in men than in women (Table 5).”
BackgroundSelf-citation
Pooled cohort study on height and risk of cancer and cancer death
Wirén, S. M., Häggström, C., Ulmer, H., Manjer, J., Bjørge, T., Nagel, G., Johansen, D., Hallmans, G., Engeland, A., Concin, H., et al. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0317-7 · Cited by 95 · see citing works
Thyroid cancer incidence attributable to overdiagnosis in the United States 1981–2011
O’Grady, T. J., Gates, M. A., & Boscoe, F. P. (2015) · International Journal of Cancer · doi:10.1002/ijc.29634 · Cited by 92 · cited 1× · see citing works
“A recent study estimated that over the past 2 decades, about one-half of all papillary thyroid cancers diagnosed in women, and 40% of those in men aged 50 years, were clinically irrelevant.(40) However, increases across tumor size and stage, as well as for follicular carcinoma (a more aggressive subtype), suggest that…”
Background
Testing the equality of two dependent kappa statistics
Donner, A. P., Shoukri, M. M., Klar, N. S., & Bartfay, E. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3 · Cited by 90 · see citing works
Measurement of Progress Against Cancer
Extramual Committee To Assess Measures of Progress Against Cancer (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.10.825 · Cited by 74 · see citing works
Measurement of progress against cancer. Extramural Committee to Assess Measures of Progress Against Cancer.
Sondik, E. J. (1990) · PubMed · Cited by 72 · see citing works
Height as an Explanatory Factor for Sex Differences in Human Cancer
Walter, R. B., Brasky, T. M., Buckley, S. A., Potter, J. D., & White, E. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt102 · Cited by 65 · cited 1× · see citing works
“Adult height, which is determined by genetics and childhood nutrition, is positively associated with cancer incidence and death in both men and women,(22) and has been estimated to account for one-third of the sex differences in cancer risk.(23) For adults aged younger than 50 years, however, cancer risk is higher for…”
Background
Predicting US‐ and state‐level cancer counts for the current calendar year
Zhu, L., Pickle, L. W., Ghosh, K., Naishadham, D., Portier, K. M., Chen, H., Kim, H., Zou, Z., Cucinelli, J. E., Kohler, B., et al. (2012) · Cancer · doi:10.1002/cncr.27405 · Cited by 58 · cited 2× · see citing works
“For complete details of the case projection methodology, please refer to Zhu et al.(20) New cases of female breast carcinoma in situ and mela-”
Self-citation
Predicting US‐ and state‐level cancer counts for the current calendar year
Chen, H., Portier, K. M., Ghosh, K., Naishadham, D., Kim, H., Zhu, L., Pickle, L. W., Krapcho, M. F., Scoppa, S., Jemal, A., et al. (2012) · Cancer · doi:10.1002/cncr.27404 · Cited by 53 · see citing works
Self-citation
Treatments for chronic myeloid leukemia: a qualitative systematic review
Mitchell, S., Ferdinand, Tumur, & Batson, S. (2012) · Journal of Blood Medicine · doi:10.2147/jbm.s33380 · Cited by 49 · see citing works
Progress Born From a Legacy of Collaboration
Hudson, M. M., Meyer, W. H., & Pui, C. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4535 · Cited by 24 · cited 1× · see citing works
“The substantial progress for all of the major childhood cancers reflects both improvements in treatment and high levels of participation in clinical trials.(59)”
Background
Alternate Ranging Methods for Cancer Mortality Maps
Grauman, D. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.534 · Cited by 19 · see citing works
Deaths
Murphy, O. M. G. (2015) · Veterinary Record · doi:10.1136/vr.h753 · Cited by 18 · see citing works

Flagged first, then by citations

1 of the 66 references couldn’t be matched to a known paper.

Sorted by citations

Cancer statistics, 2020
Siegel, R. L., Miller, K. D., & Jemal, A. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21590 · Cited by 20,444 · see citing works
Self-citation
Cancer statistics, 2019
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160 · see citing works
Self-citation
Cancer Statistics, 2021
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522 · see citing works
Self-citation
Cancer Statistics, 2017.
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712 · see citing works
Self-citation
Cancer treatment and survivorship statistics, 2016
Miller, K. D., Siegel, R. L., Lin, C. C., Mariotto, A. B., Kramer, J. L., Rowland, J. H., Stein, K. D., Alteri, R., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21349 · Cited by 6,066 · see citing works
Self-citation
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
Campanella, G., Hanna, M. G., Geneslaw, L., Miraflor, A., Werneck Krauss Silva, V., Busam, K. J., Brogi, E., Reuter, V. E., Klimstra, D. S., & Fuchs, T. J. (2019) · Nature Medicine · doi:10.1038/s41591-019-0508-1 · Cited by 2,799 · see citing works
Renal cell carcinoma
Hsieh, J. J.-D., Purdue, M. P., Signoretti, S., Swanton, C., Albiges, L. K., Schmidinger, M., Heng, D. Y. C., Larkin, J., & Ficarra, V. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.9 · Cited by 2,797 · see citing works
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590 · see citing works
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
Hamdy, F. C., Donovan, J., Lane, J. A., Mason, M. D., Metcalfe, C. D., Holding, P., Davis, M., Peters, T. J., Turner, E. L., Martin, R. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606220 · Cited by 2,642 · see citing works
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Novello, S., Barlesi, F., Califano, R., Cufer, T., Ekman, S., Levra, M. G., Kerr, K., Popat, S., Reck, M., Senan, S., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw326 · Cited by 2,631 · see citing works
Skin lesion analysis toward melanoma detection: A challenge at the 2017 International symposium on biomedical imaging (ISBI), hosted by the international skin imaging collaboration (ISIC)
Codella, N. C. F., Gutman, D., Celebi, M. E., Helba, B., Marchetti, M. A., Dusza, S. W., Kalloo, A., Liopyris, K., Mishra, N., Kittler, H., et al. (2018) · 2018 IEEE 15th International Symposium on Biomedical Imaging (ISBI 2018) · doi:10.1109/isbi.2018.8363547 · Cited by 2,620 · see citing works
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111 · see citing works
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
Ostrom, Q. T., Gittleman, H. R., Truitt, G., Boscia, A. L., Kruchko, C. A., & Barnholtz‐Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy131 · Cited by 2,158 · see citing works
Integrated genomic characterization of pancreatic ductal adenocarcinoma
Raphael, B. J., Hruban, R. H., Aguirre, A. J., Moffitt, R. A., Yeh, J. J., Stewart, C., Robertson, A. G., Cherniack, A. D., Gupta, M., Getz, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.007 · Cited by 2,019 · see citing works
Ultrasound Elastography: Review of Techniques and Clinical Applications
Sigrist, R. M. S., Liau, J., Kaffas, A. E., Chammas, M. C., & Willmann, J. K. (2017) · Theranostics · doi:10.7150/thno.18650 · Cited by 1,887 · see citing works
Integrated genomic characterization of oesophageal carcinoma
Sun, Q., Kelsen, D. P., Wiznerowicz, M., Lu, Y., Marra, M. A., Wan, Y., Weinhold, N., Wong, A. M., Carvalho, A. L., Luketich, J. D., et al. (2017) · Nature · doi:10.1038/nature20805 · Cited by 1,833 · see citing works
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
Ostrom, Q. T., Gittleman, H. R., Liao, P., Vecchione-Koval, T., Wolinsky, Y., Kruchko, C. A., & Barnholtz‐Sloan, J. S. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox158 · Cited by 1,824 · see citing works
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,741 · see citing works
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
Pritchard, C. C., Mateo, J., Walsh, M. F., De Sarkar, N., Abida, W., Beltran, H., Garofalo, A., Gulati, R., Carreira, S., Eeles, R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603144 · Cited by 1,680 · see citing works
The landscape of genomic alterations across childhood cancers
ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature · doi:10.1038/nature25480 · Cited by 1,572 · see citing works
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040
Arnold, M., Singh, D., Laversanne, M., Vignat, J., Vaccarella, S., Meheus, F., Cust, A. E., de Vries, E., Whiteman, D. C., & Bray, F. (2022) · JAMA Dermatology · doi:10.1001/jamadermatol.2022.0160 · Cited by 1,535 · see citing works
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424 · see citing works
Extracellular vesicles in cancer — implications for future improvements in cancer care
Xu, R., Rai, A., Chen, M., Suwakulsiri, W., Greening, D. W., & Simpson, R. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0036-9 · Cited by 1,435 · see citing works
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Pushalkar, S., Hundeyin, M., Daley, D., Zambirinis, C. P., Kurz, E., Mishra, A., Mohan, N., Aykut, B., Usyk, M., Torres, L. E., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1134 · Cited by 1,400 · see citing works
IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Biffi, G., Oni, T. E., Spielman, B., Hao, Y., Elyada, E., Park, Y., Preall, J., & Tuveson, D. A. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0710 · Cited by 1,360 · see citing works
Ovarian cancer
Matulonis, U. A., Sood, A. K., Fallowfield, L., Howitt, B. E., Sehouli, J., & Karlan, B. Y. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.61 · Cited by 1,362 · see citing works
Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
Planchard, D., Smit, E. F., Groen, H. J. M., Mazières, J., Besse, B., Helland, Å., Giannone, V., D'amelio, A. M., Zhang, P., Mookerjee, B., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30679-4 · Cited by 1,360 · see citing works
Systemic Therapy for Metastatic Renal-Cell Carcinoma
Choueiri, T. K., & Motzer, R. J. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1601333 · Cited by 1,287 · see citing works
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245 · see citing works
Self-citation
Multiple myeloma
Kumar, S. K., Rajkumar, S. V., Kyle, R. A., van Duin, M., Sonneveld, P., Mateos, M., Gay, F., & Anderson, K. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.46 · Cited by 1,235 · see citing works
Colorectal Cancer Incidence Patterns in the United States, 1974–2013
Siegel, R. L., Fedewa, S. A., Anderson, W. F., Miller, K. D., Ma, J., Rosenberg, P. S., & Jemal, A. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw322 · Cited by 1,229 · see citing works
Self-citation
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009–2013
Ostrom, Q. T., Gittleman, H. R., Xu, J. C., Kromer, C. M., Wolinsky, Y., Kruchko, C. A., & Barnholtz‐Sloan, J. S. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now207 · Cited by 1,205 · see citing works
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Escudier, B., Porta, C., Schmidinger, M., Rioux-Leclercq, N., Bex, A., Khoo, V., Grünwald, V., Gillessen, S., & Horwich, A. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz056 · Cited by 1,151 · see citing works
Non-Hodgkin lymphoma
Armitage, J. O., Gascoyne, R. D., Lunning, M. A., & Cavalli, F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32407-2 · Cited by 1,182 · see citing works
Automated Melanoma Recognition in Dermoscopy Images via Very Deep Residual Networks
Yu, L., Chen, H., Dou, Q., Qin, J., & Heng, P.-A. (2017) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2016.2642839 · Cited by 1,140 · see citing works
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.
Shaverdian, N., Lisberg, A. E., Bornazyan, K., Veruttipong, D., Goldman, J. W., Formenti, S. C., Garon, E. B., & Lee, P. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30380-7 · Cited by 1,091 · see citing works
Screening for Thyroid Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082 · see citing works
Deep learning-based multi-omics integration robustly predicts survival in liver cancer
Chaudhary, K., Poirion, O. B., Lu, L., & Garmire, L. X. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0853 · Cited by 1,091 · see citing works
Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer
Iyengar, P., Wardak, Z., Gerber, D. E., Tumati, V., Ahn, C. W., Hughes, R. S., Dowell, J. E., Cheedella, N. K. S., Nedzi, L. A., Westover, K. D., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3501 · Cited by 1,051 · see citing works
Curcumin and Cancer
Giordano, A., & Tommonaro, G. (2019) · Nutrients · doi:10.3390/nu11102376 · Cited by 1,029 · see citing works
Classification of breast cancer histology images using Convolutional Neural Networks
Araújo, T., Aresta, G., Castro, E., Rouco, J., Aguiar, P., Eloy, C., Polónia, A., & Campilho, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177544 · Cited by 1,017 · see citing works
Gut microbiota modulation of chemotherapy efficacy and toxicity
Alexander, J. L., Wilson, I. D., Teare, J., Marchesi, J. R., Nicholson, J. K., & Kinross, J. M. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.20 · Cited by 970 · see citing works
NCCN Guidelines Insights: Colon Cancer, Version 2.2018
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y., Ciombor, K. K., Cohen, S. A., Cooper, H. S., Deming, D. A., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0021 · Cited by 989 · see citing works
Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals
Prasad, S., Gupta, S. C., & Tyagi, A. K. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.042 · Cited by 981 · see citing works
KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
Waters, A. M., & Der, C. J. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031435 · Cited by 875 · see citing works
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Study, T. P., Schumacher, F. R., (APCB), A. P. C. B., Study, T. I., Canary PASS Investigators, Breast and Prostate Cancer Cohort Consortium (BPC3), The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, (CAPS), C. O. T. P. I. S., Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS), The Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium, et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0142-8 · Cited by 902 · see citing works
Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
Planchard, D., Besse, B., Groen, H. J. M., Souquet, P.-J., Quoix, E., Baik, C. S., Barlesi, F., Kim, T. M., Mazieres, J., Novello, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30146-2 · Cited by 888 · see citing works
2016 US lymphoid malignancy statistics by World Health Organization subtypes
Teras, L. R., DeSantis, C. E., Cerhan, J. R., Morton, L. M., Jemal, A., & Flowers, C. R. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21357 · Cited by 1,125 · see citing works
Self-citation
Current Challenges and Opportunities in Treating Glioblastoma
Shergalis, A. G., Bankhead, A., Luesakul, U., Muangsin, N., & Neamati, N. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014944 · Cited by 847 · see citing works
German Multicenter Study Investigating 177 Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
Rahbar, K., Ahmadzadehfar, H., Kratochwil, C., Haberkorn, U., Schäfers, M. A., Essler, M., Baum, R. P., Kulkarni, H., Schmidt, M. C., Drzezga, A. E., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.183194 · Cited by 849 · see citing works
Treatment of renal cell carcinoma: Current status and future directions
Barata, P. C., & Rini, B. I. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21411 · Cited by 828 · see citing works
Bladder cancer
Şanlı, Ö., Dobruch, J. T., Knowles, M. A., Burger, M., Mehrdad Alemozaffar, A., Nielsen, M. E., & Lotan, Y. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.22 · Cited by 819 · see citing works
Circular RNA and its mechanisms in disease: From the bench to the clinic
Han, B., Chao, J., & Yao, H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.010 · Cited by 784 · see citing works
The biological activities, chemical stability, metabolism and delivery systems of quercetin: A review
Wang, W., Sun, C., Mao, L., Ma, P., Liu, F., Yang, J., & Gao, Y. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.07.004 · Cited by 786 · see citing works
ACG Clinical Guidelines: Colorectal Cancer Screening 2021
Shaukat, A., Kahi, C. J., Burke, C. A., Rabeneck, L., Sauer, B. G., & Rex, D. K. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001122 · Cited by 853 · see citing works
Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
Wu, S., & Shih, J. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0777-1 · Cited by 788 · see citing works
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
D'Angelo, S. P., Mahoney, M. R., Van Tine, B. A., Atkins, J., Milhem, M. M., Jahagirdar, B. N., Antonescu, C. R., Horvath, E., Tap, W. D., Schwartz, G. K., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30006-8 · Cited by 759 · see citing works
Using Machine Learning Algorithms for Breast Cancer Risk Prediction and Diagnosis
Asri, H., Mousannif, H., Moatassime, H. A., & Noël, T. (2016) · Procedia Computer Science · doi:10.1016/j.procs.2016.04.224 · Cited by 773 · see citing works
Multiple myeloma epidemiology and survival: A unique malignancy
Kazandjian, D. G. (2016) · Seminars in Oncology · doi:10.1053/j.seminoncol.2016.11.004 · Cited by 765 · see citing works
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non–Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
Chun, S. G., Hu, C., Choy, H., Komaki, R. U., Timmerman, R. D., Schild, S. E., Bogart, J. A., Dobelbower, M. C., Bosch, W. R., Galvin, J. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.1378 · Cited by 747 · see citing works
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression
Parhi, L., Alon-Maimon, T., Sol, A., Nejman, D., Shhadeh, A., Fainsod-Levi, T., Yajuk, O., Isaacson, B., Abed, J., Maalouf, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16967-2 · Cited by 716 · see citing works
Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study
Gettinger, S. N., Horn, L., Jackman, D. M., Spigel, D. R., Antonia, S. J., Hellmann, M. D., Powderly, J. D., Heist, R. S., Sequist, L. V. D., Smith, D. C., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.0412 · Cited by 740 · see citing works
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016
Ettinger, D. S., Wood, D. E., Akerley, W., Bazhenova, L. A., Borghaei, H., Camidge, D. R., Cheney, R. T., Chirieac, L. R., D’Amico, T. A., Dilling, T. J., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0031 · Cited by 742 · see citing works
An update on larynx cancer
Steuer, C. E., El‐Deiry, M. W., Parks, J. R., Higgins, K. A., & Saba, N. F. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21386 · Cited by 718 · see citing works
Metallothionein‐1G facilitates sorafenib resistance through inhibition of ferroptosis
Sun, X., Niu, X., Chen, R., He, W., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28574 · Cited by 707 · see citing works
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma
Coroller, T. P., Grossmann, P., Hou, Y., Rios Velazquez, E., Leijenaar, R. T. H., Hermann, G., Lambin, P., Haibe-Kains, B., Mak, R. H., & Aerts, H. J. W. L. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.02.015 · Cited by 695 · see citing works
Mucosal microbiome dysbiosis in gastric carcinogenesis
Coker, O. O., Dai, Z., Nie, Y., Zhao, G., Cao, L., Nakatsu, G., Wu, W. K., Wong, S. H., Chen, Z., Sung, J. J. Y., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314281 · Cited by 695 · see citing works
Automatic skin lesion segmentation using deep fully convolutional networks with jaccard distance.
Yuan, Y., Chao, M., & Lo, Y.-C. (2017) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2017.2695227 · Cited by 687 · see citing works
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
Seca, A. M. L., & Pinto, D. C. G. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010263 · Cited by 701 · see citing works
Plant-derived anticancer agents: A green anticancer approach
Iqbal, J., Abbasi, B. A., Mahmood, T., Kanwal, S., Ali, B., Shah, S. A., & Khalil, A. T. (2017) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2017.10.016 · Cited by 690 · see citing works
Review of cancer from perspective of molecular
Hassanpour, S. H., & Dehghani, M. A. (2017) · Journal of Cancer Research and Practice · doi:10.1016/j.jcrpr.2017.07.001 · Cited by 688 · see citing works
Brain Tumor Classification Using Convolutional Neural Network
Abiwinanda, N., Hanif, M., Hesaputra, S. T., Handayani, A., & Mengko, T. R. (2018) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-981-10-9035-6_33 · Cited by 677 · see citing works
Noncoding Effects of Circular RNA CCDC66 Promote Colon Cancer Growth and Metastasis
Hsiao, K., Lin, Y., Gupta, S. K., Chang, N., Yen, L., Sun, H. S., & Tsai, S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1883 · Cited by 670 · see citing works
Estimating Survival in Patients With Lung Cancer and Brain Metastases
Sperduto, P. W., Yang, J. T., Beal, K. P., Pan, H. Y., Brown, P. D., Bangdiwala, A. S., Shanley, R., Yeh, N., Gaspar, L. E., Braunstein, S. E., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3834 · Cited by 662 · see citing works
Fruits, vegetables, and health: A comprehensive narrative, umbrella review of the science and recommendations for enhanced public policy to improve intake
Wallace, T. C., Bailey, R. L., Blumberg, J. B., Burton-Freeman, B., Chen, C.-Y. O., Crowe-White, K. M., Drewnowski, A., Hooshmand, S., Johnson, E., Lewis, R., et al. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1632258 · Cited by 638 · see citing works
Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes
Winer, A., Adams, S., & Mignatti, P. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0646 · Cited by 659 · see citing works
Colorectal cancer population screening programs worldwide in 2016: An update
Navarro, M., Nicolas, A., Ferrandez, A., & Lanas, A. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i20.3632 · Cited by 611 · see citing works
The role of the microbiome in cancer development and therapy
Bhatt, A. P., Redinbo, M. R., & Bultman, S. J. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21398 · Cited by 653 · see citing works
Real-time differentiation of adenomatous and hyperplastic diminutive colorectal polyps during analysis of unaltered videos of standard colonoscopy using a deep learning model
Byrne, M. F., Chapados, N., Soudan, F., Oertel, C., Linares Pérez, M., Kelly, R., Iqbal, N., Chandelier, F., & Rex, D. K. (2019) · Gut · doi:10.1136/gutjnl-2017-314547 · Cited by 635 · see citing works
Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Massarweh, N. N., & El‐Serag, H. B. (2017) · Cancer Control · doi:10.1177/1073274817729245 · Cited by 637 · see citing works
Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging
Xu, Y., Hosny, A., Zeleznik, R., Parmar, C., Coroller, T. P., Franco, I. “., Mak, R. H., & Aerts, H. J. W. L. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2495 · Cited by 635 · see citing works
New Horizons for Precision Medicine in Biliary Tract Cancers
Valle, J. W., Lamarca, Á., Goyal, L., Barriuso, J., & Zhu, A. X. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0245 · Cited by 626 · see citing works
Alginate-based hydrogels as drug delivery vehicles in cancer treatment and their applications in wound dressing and 3D bioprinting
Abasalizadeh, F., Moghaddam, S. V., Alizadeh, E., akbari, E., Kashani, E., Fazljou, S. M. B., Torbati, M., & Akbarzadeh, A. (2020) · Journal of Biological Engineering · doi:10.1186/s13036-020-0227-7 · Cited by 618 · see citing works
American Cancer Society Head and Neck Cancer Survivorship Care Guideline
Cohen, E. E. W., LaMonte, S. J., Erb, N. L., Beckman, K. L., Sadeghi, N., Hutcheson, K. A., Stubblefield, M. D., Abbott, D. M., Fisher, P., Stein, K., et al. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21343 · Cited by 620 · see citing works
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non–Small Cell Lung Carcinoma: A Systematic Review and Meta-analysis
Lee, C. K., Man, J., Lord, S., Cooper, W., Links, M., Gebski, V., Herbst, R. S., Gralla, R. J., Mok, T., & Yang, J. C.-H. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.4427 · Cited by 598 · see citing works
Pancreatic cancer: A review of epidemiology, trend, and risk factors
Hu, J.-X., Zhao, C., Chen, W.-B., Liu, Q., Li, Q.-W., Lin, Y., & Gao, F. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i27.4298 · Cited by 602 · see citing works
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Cohen, J. D., Javed, A. A., Thoburn, C. J., Wong, F., Tie, J., Gibbs, P., Schmidt, C. M., Yip-Schneider, M., Allen, P. J., Schattner, M. A., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704961114 · Cited by 581 · see citing works
Circadian Rhythm Disruption Promotes Lung Tumorigenesis
Papagiannakopoulos, T., Bauer, M. R., Davidson, S. M., Heimann, M., Subbaraj, L., Bhutkar, A., Bartlebaugh, J., Vander Heiden, M. G., & Jacks, T. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.001 · Cited by 557 · see citing works
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Abu‐Rustum, N. R., Yashar, C. M., Arend, R. C., Barber, E. L., Bradley, K. A., Brooks, R. A., Campos, S. M., Chino, J., Chon, H. S., Chu, C., et al. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.0006 · Cited by 581 · see citing works
Breast Cancer Epidemiology and Risk Factors
Rojas, K. E., & Stuckey, A. R. (2016) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000239 · Cited by 573 · see citing works
Attention Residual Learning for Skin Lesion Classification
Zhang, J., Xie, Y., Xia, Y., & Shen, C. (2019) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2019.2893944 · Cited by 573 · see citing works
Trends in the incidence, treatment, and survival of patients with lung cancer in the last four decades
Lu, T., Yang, X., Huang, Y., Zhao, M., Li, M., Ma, K., Yin, J., Zhan, C., & Wang, Q. (2019) · Cancer Management and Research · doi:10.2147/cmar.s187317 · Cited by 565 · see citing works
Global liver disease burdens and research trends: Analysis from a Chinese perspective
Xiao, J., Wang, F., Wong, N.-K., He, J., Rui, Z., Sun, R., Xu, Y., Liu, Y., Li, W., Koike, K., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.004 · Cited by 554 · see citing works
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics
Vangijzegem, T., Stanicki, D., & Laurent, S. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1554647 · Cited by 553 · see citing works
GSH‐Depleted PtCu 3 Nanocages for Chemodynamic‐ Enhanced Sonodynamic Cancer Therapy
Zhong, X., Wang, X., Cheng, L., Tang, Y., Zhan, G., Gong, F., Zhang, R., Hu, J., Liu, Z., & Yang, X. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201907954 · Cited by 541 · see citing works
Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis
Kirkegård, J., Mortensen, F. V., & Cronin-Fenton, D. P. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.218 · Cited by 538 · see citing works
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
Motoi, F., Kosuge, T., Ueno, H., Yamaue, H., Satoi, S., Sho, M., Honda, G., Matsumoto, I., Wada, K., Furuse, J., et al. (2018) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyy190 · Cited by 531 · see citing works
Effect of Exercise and Nutrition Prehabilitation on Functional Capacity in Esophagogastric Cancer Surgery: A Randomized Clinical Trial
Minnella, E. M., Awasthi, R., Loiselle, S.-E., Agnihotram, R. V., Ferri, L. E., & Carli, F. (2018) · JAMA Surgery · doi:10.1001/jamasurg.2018.1645 · Cited by 522 · see citing works
Targeting ALK: Precision Medicine Takes on Drug Resistance
Lin, J. J., Riely, G. J., & Shaw, A. T. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1123 · Cited by 528 · see citing works
DNA Damage, Mutagenesis and Cancer
Basu, A. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040970 · Cited by 524 · see citing works

Authors: Siegel, R. L., Miller, K. D., & Jemal, A.
Affiliations: American Cancer Society (US)
Corresponding author: Siegel, Rebecca L.
ORCID: Siegel, Rebecca L.
Miller, Kimberly D.
Jemal, Ahmedin
Venue: CA: A Cancer Journal for Clinicians
Publisher: Wiley
Published: 2016-01
Volume: 66
Issue: 1
Pages: 7-30
ISSN: 0007-9235 (ISSN-L)
1542-4863
DOI: 10.3322/caac.21332
OpenAlex: W2235523093
Cited by: 16,003
References: 66
Citations by year: 2026: 50 · 2025: 222 · 2024: 343 · 2023: 563 · 2022: 795 · 2021: 1226 · 2020: 1590 · 2019: 2001 · 2018: 3108 · 2017: 4325 · 2016: 1700 · 2015: 38 · 2014: 28 · 2013: 3 · 2012: 1
FWCI: 2000.05
Type: journal article
Language: en
Open access: gold
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 6 d)
Locations: CA A Cancer Journal for Clinicians (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
Health Sciences › Medicine › Reproductive Medicine › Science, Research, and Medicine
Keywords: cancer incidence, cancer mortality, cancer survival, cancer projections, incidence trends, prostate cancer, liver cancer, pancreatic cancer, endometrial cancer, brain cancer, childhood cancer, cancer control, cancer research funding
MeSH terms: American Cancer Society, Female, Humans, Male, Neoplasms, Registries, United States, Incidence, Survival Rate, Sex Distribution, SEER Program, Racial Groups

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cancer statistics, 2016

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks